[Likely serotoninergic syndrome from an interaction between amitryptiline, paroxetine, and linezolid].
Morales-Molina
J A
JA
Mateu-de Antonio
J
J
Grau Cerrato
S
S
Marín Casino
M
M
D000081:Acetamides / Q000009:adverse effects* / Q000494:pharmacology; D000368:Aged; D000639:Amitriptyline / Q000009:adverse effects* / Q000494:pharmacology; D000890:Anti-Infective Agents / Q000009:adverse effects* / Q000494:pharmacology; D000929:Antidepressive Agents, Tricyclic / Q000009:adverse effects* / Q000494:pharmacology; D004347:Drug Interactions; D005260:Female; D006801:Humans; D000069349:Linezolid; D023303:Oxazolidinones / Q000009:adverse effects* / Q000494:pharmacology; D017374:Paroxetine / Q000009:adverse effects* / Q000494:pharmacology; D020230:Serotonin Syndrome / Q000139:chemically induced*; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects* / Q000494:pharmacology
D000081:Acetamides; D000639:Amitriptyline; D000890:Anti-Infective Agents; D000929:Antidepressive Agents, Tricyclic; D000069349:Linezolid; D023303:Oxazolidinones; D017374:Paroxetine; D017367:Selective Serotonin Reuptake Inhibitors